Xlumena Closes $7M Series B
Mountain View, Calif.-based Xlumena has closed its Series B financing round with $7 million. The company develops technology for interventional endoscopists and endoscopic surgeons. New investor Aperture Venture Partners led the round. Western Technology Investment also participated in the round, as did Prism Ventures, Charter Life Sciences and Ascent Biomedical Ventures. As a result, Eric Sillman of Aperture Venture Partners, and Avi Kometz of Ascent Biomedical Ventures will join Xlumena's board.
29 April 2011•2 mins read
